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Abstract
Objectives

Three-dimensional (3D) bioprinting, a method derived from additive manufacturing technology, is a recent and
ongoing trend for the construction of 3D volumetric structures. The purpose of this systematic review is to
summarize evidence from existing human and animal studies assessing the application of 3D printing on bone
repair and regeneration in the craniofacial region.

Data & sources

A rigorous search of all relevant clinical trials and case series was performed, based on specific inclusion and
exclusion criteria. The search was conducted in all available electronic databases and sources, supplemented by
a manual search, in December 2017.

Study selection

43 articles (6 human and 37 animal studies) fulfilled the criteria. The human studies included totally 81 patients
with craniofacial bone defects. Titanium or hydroxylapatite scaffolds were most commonly implanted. The
follow-up period ranged between 6 and 24 months. Bone repair was reported successful in nearly every case,
with minimal complications. Also, animal intervention studies used biomaterials and cells in various
combination, offering insights into the techniques, through histological, biochemical, histomorphometric and
microcomputed tomographic findings. The results in both humans and animals, though promising, are yet to be
verified for clinical impact.

Conclusions

Future research should be focused on well-designed clinical trials to confirm the short- and long- term efficacy of
3D printing strategies for craniofacial bone repair.

Clinical significance

Emerging 3D printing technology opens a new era for tissue engineering. Humans and animals on application of
3D printing for craniofacial bone repair showed promising results which will lead clinicians to investigate more
thoroughly alternative therapeutic methods for craniofacial bone defects.
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1. Introduction
1.1. Background

Three-dimensional (3D) bioprinting technology will play a pivotal role in medicine, offering a promising potential
for bone reconstruction, rehabilitation and regeneration [1,2] and expanding treatment options in many field of
operation [3]. The technique was first described in 1986 by Charles W. Hull under the name of stereolithography
[4]. Since then, many diversified methods and manufacturing techniques have emerged, keeping to the same
fundamental goal - to create intricate 3D structures that mimic the external and internal architecture of the
hosted site [5] and provide essential framework for cell attachment and migration, thereby initiating tissue
regeneration. Alternatively, such a custom-made framework behaves as filling material that rehabilitates the
impaired site; 3D scaffolds, seeded with signaling biomolecules and stem cells, have recently been successfully
transplanted into intended defects [6,7].

There is a variety of terminology for describing 3D printing, including: additive manufacturing (AM), solid
freeform fabrication (SFF) and rapid prototyping (RP). 3D printing technologies involve building a well-defined
3D structure from a computer-aided design (CAD) model using layer by layer arrays [8]. The information for
designing the model is collected by medical imaging technology, mainly computed tomography (CT)
and magnetic resonance imaging (MRI). The acquired raw imaging data are processed and reconstructed as a
volumetric model, which is then transmitted to a 3D bioprinter system. Computer-aided manufacturing (CAM)
tools are used to produce 3D structures, based on the anatomical information of the tissue, to be regenerated
or reconstructed. Finally, 3D printing scaffolds are fabricated, by addition of layered biological materials, with
custom-made external shape and internal porosity, enriched with signaling biomolecules and seeding cells in
several combinations [9,10] (Fig. 1).

Fig. 1. Process of 3D bioprinting.

1.2. Categories of 3D printing systems

The technology of 3D tissue bioprinting comprises three main categories of printing systems: inkjet printers,
laser-assisted printers and microextrusion printers. All these systems share the same coordinated spatial
motion, differing in their bioink dispensing mechanisms. Factors such as surface resolution, biological material
selection and cell viability, need to be taken into account to choose the appropriate printing system [11].
Inkjet printers are also known as drop-on-demand printers; controlled volumes of liquid are delivered to
predefined sites of the substrate via diverse mechanisms [12]. Inkjet printers use thermal, microvalve or acoustic
forces to create and eject droplets of biomaterial through an orifice and thereby to form the tissue substitute.
Thermal inkjet printers use a heating element to separate the liquid into drops [13]. Microvalve inkjet printers

use consecutive opening/closing of a small valve, controlled by an electromagnetic field to expel the liquid [14].
Acoustic inkjet printers use the rapid change in shape of a piezoelectric crystal to generate an impulse in the
liquid [15].
Laser-assisted printers are based on laser-induced forward transfer (LIFT) technology [16]. Typically, they consist
of four components: a pulsed laser beam, a focusing system, a transparent glass slide (coated with laser-energy
absorbing layer), and a layer of biological material/cells. The laser pulse is transferred to the absorbing layer and
is then directed to the layer of biomaterial, generating a high-pressure bubble that propels the biomaterial dropby-drop toward the receiving substrate. Variations of laser-based 3D printers include selective laser sintering
(SLS), stereolithography (SLA) and selective laser melting (SLM) [17].
Microextrusion printers are robotically controlled dispensing systems, consisting of a material-handling print
head, a dispensing system and a stage capable of three dimensional movement [18]. The dispensing system can
be pneumatic or mechanical. Pneumatic extrusion is by use of compressed gas, whereas mechanical dispensing
systems use metallic screws or pistons to push the material out, through a nozzle, on the stage [19]. The latter
dispensing system provides more precise control over the material flow. The layers of the extruded biomaterial
are deposited in continuous struts, rather than droplets, each layer serving as the foundation for the next [11].
Extrusion based variations of 3D printers include fused deposition modeling (FDM) and robocasting/direct ink
writing (DIW) [20] (Fig. 1).

1.3. Objectives

The craniofacial complex comprises regions of diverse structural demands, each requiring appropriate design
and materials for scaffolding, reinforced or not with biomolecules and cells for bone repair. A good
understanding of the manufacturing concepts, biological mechanisms and applications of 3D printing is
necessary for comparison with the traditional methods of bone reconstruction and consideration of such
methods in treatment planning.
In light of the considerable differences among techniques, this systematic review sought to summarize evidence
from existing human and animal studies assessing the application of 3D printing on bone repair and
regeneration in the craniofacial region as well as to identify the success factors and potential complications of
this intervention.

2. Data & sources
2.1. Protocol

The present systematic review was conducted according to the guidelines of the Cochrane Handbook for
Systematic Reviews of Interventions version 5.1.0. [21] and followed the PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) guidelines [22].

2.2. Information sources and literature search strategy

The search strategy was conducted in the electronic databases of MEDLINE, EMBASE, COCHRANE LIBRARY, in
October 2016 and was updated December 2017. Clinical Trials (www.clinicaltrials.gov) and National Research
Register (www.controlled-trials.com) were also searched for unpublished studies. Attempts for personal
communication with the authors were made in cases of incomplete data. Various combinations of the following
keywords were inserted in according to the instructions of each search engine: 3D printing, 3D printed,
bioprinted, bioprinting, 3D scaffold, bone, cranial, craniofacial, facial, craniomaxillofacial, maxilla, mandible,
dental, dentistry. No language, publication status or year restriction was applied. Cross-checking of the included
articles and relevant reviews, as well as a manual web search was conducted for unidentified article. The list of
databases searched with the corresponding strategies is presented in Supplementary Table 1.

2.3. Inclusion/exclusion criteria

The eligible studies were chosen based on inclusion/exclusion criteria that were determined a priori according to
the Participant-Intervention-Comparison-Outcome-Study (PICOS) schema (Table 1).
Table 1. Eligibility criteria used for the study selection.
Category
Participant
characteristics
Intervention

Comparison
Outcome

Study design

Inclusion Criteria
Studies on human participants of any gender with
craniofacial bone defects (congenital or acquired)
Animal interventional studies with craniofacial
bone defects (congenital or acquired)
Bone repair (reconstruction or/and regeneration)
using 3D printed implanted biomaterials as
scaffolds, solely or in combination with bone grafts,
biomolecules or cell cultures

Studies assessing bone repair after using 3D
printed implanted biomaterials
Primary: Evaluation of immediate and long-term
bone repair by histological or radiographic analysis
Secondary: evaluation of serious complications
intraoperatively and postoperatively
(e.g. handling, exposure, infection of the
biomaterial)
Randomized controlled clinical trials
Prospective controlled and uncontrolled clinical
trials
Retrospective controlled and uncontrolled clinical
trials
Case series with number of participants ≥5

Exclusion Criteria
Clinical trials with fewer than five
participants
Defects at sites other than the
craniofacial region
Bone repair using autologous bone,
allogenic bone or xenograft as the
only means of bone repair
3D printing used only for
preoperative analysis or for
simulation of a surgical case
3D printing used only for the
fabrication of surgical splints,
guides, temporary molds, dental
implants or screws
3D printing used only for soft tissue
repair
Studies assessing bone repair by
any other means of reconstruction

Unsupported opinion of expert
Books
Case reports
Case series with number of
participants <5
Observational studies
Narrative or systematic reviews

2.4. Study selection

The resulting studies after applying inclusion/exclusion criteria were first checked for duplicates, then the titles
and abstracts were screened for relevance. The final stage involved retrieving and checking the full texts. The
process was conducted independently by two of the authors (MM, GK) and any conflicts were resolved by
consulting a third author (YR).

2.5. Data extraction

Data extraction was performed independently by two authors (MM, GK) and any discrepancies in data
extraction between the two authors were likewise resolved by a third author (YR). The following data were
recorded:

a. A Study’s characteristics (author, year of publication, language, study design)
b. B Details of the type of intervention
c. C Details of outcome
In every study, the following intervention characteristics were recorded:
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
k.

A Human or animal subjects
B Type of animal (for animal studies)
C Number of subjects
D Site of defect
E Origin of defect (congenital or acquired – for human studies)
F Type of additive manufacturing
G Type of scaffold (degradable or not)
H Material of scaffold
I Biomolecules or cell seeding
J Bone graft
K Follow-up period

2.6. Quality assessment of human studies

Initially, a tool was used to rate all the included studies according to their level of evidence, based on the Oxford
Centre for Evidence-based Medicine Levels of Evidence [23].
Afterwards, the Cochrane Collaboration’s Risk of Bias Tool was used to assess the risk of bias in randomized
clinical trials [24]. Seven domains of bias (sequence generation, allocation concealment, blinding of participants
and investigators, blinding of outcome assessors, missing outcome data, selective outcome reporting, other
sources of bias) were estimated as “low”, “unclear” or “high”. A final overall classification was given to each
study as follows:
•
•
•

Low risk of bias (if all domains of the study were at low risk of bias)
Unclear risk of bias (if one or more domains of the study were unclear)
High risk of bias (if one or more domains of the study were at high risk of bias)

The ROBINS-I tool of Cochrane library was used to assess the risk of bias of non-randomized studies [25]. Seven
domains of bias (confounding, selection of participants, classification of intervention, deviations from intended
interventions, missing data, measurement of outcomes, selection of reported result) were estimated as “low”,
“moderate”, “serious”, critical” or “no information”. Each study was finally assessed as follows:
•
•
•
•
•

Low risk of bias (if all domains of the study were at low risk of bias)
Moderate risk of bias (if all domains of the study were at low or moderate risk of bias)
Serious risk of bias (if at least one domain were at serious risk of bias)
Critical risk of bias (if at least one domain were at critical risk of bias)
No information (if there is a lack of information in one or more domains of bias and there is no clear
indication that the study is at serious or critical risk of bias)

Several confounders were considered for the assessment of risk of bias and these were the age of the patient,
the oral hygiene, the initial periodontal health, the nature of the defect, the site of defects and force loading
parameters.
It should be stated that the above tool was not applied to case studies without controls, because the risk of bias
is inherently high and these studies were regarded to have low credibility.

2.7. Quality assessment of animal studies

The animal studies were qualitatively assessed according to the National Centre for the Replacement,
Refinement, and Reduction of Animals in Research (NC3Rs) survey of experimental design and reporting, which
is based on the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines, as modified by Leim et
al. [[26], [27], [28]]. A checklist of domains was applied in all included studies, which were further graded into 3
categories based on the percentage of the essential information they contained: 75% or more of positive
answers (A), 50–74% (B), and less than 50% (C).
The potential bias of the animal studies was assessed using a simplified version of the Cochrane Collaboration’s
risk of bias tool for systematic reviews of interventions [21].

2.8. Outcomes evaluation

The outcome assessment was conducted with regard to the inclusion-exclusion criteria. The primary outcome
was the immediate and long-term bone repair, for the time of observation, assessed by histological or
radiographic evaluation. The secondary outcome was the presence of serious complications, either peri- or postoperatively (i.e. handling, exposure, infection of biomaterial) that may affect the success of the intervention.
Human trials were regarded as successful if the aesthetic and functional result was satisfactory in accordance to
primary and secondary outcomes.

3. Results
The search yielded 838 articles; 803 from the databases and 35 from other sources. One hundred thirty-eight full
texts were retrieved out of these initial results, after eliminating duplicates and checking titles and abstracts.
Only 43 articles fulfilled the predetermined criteria, including 6 human and 37 animal studies. The flow diagram
of the systematic review is presented in Fig. 2.

Fig. 2. Flow diagram of the systematic review.

4. Human studies
4.1. Study selection

All 6 human studies were published in scientific journals during the period 2009–2017, 5 in English and 1 in
Chinese [29]. They consisted of two prospective clinical trials (one randomized and one non-randomized) [30,31]
and four retrospective case series [29,[32], [33], [34]]. The two clinical trials compared 3D printed scaffolds of
different type, biomaterials and with other techniques [30,31].

4.2. Study characteristics

Overall, the studies included 81 patients; 19 patients from the clinical trials and 62 patients from the case series.
The clinical trial included six to 13 patients each [30,31] the case series including eight to 23 patients each
[29,[32], [33], [34]].
Three-dimensional printed biomaterials were most often implanted in mandibular bone defects, followed by
calvarial, maxillary and nasal defects. The vast majority of the defects were acquired after tumor resection or
trauma. Laser printing was most commonly used [31,32,34], followed by inkjet printing [29,33] and
microextrusion [30]. Non-absorbable biomaterials were usually applied. Hydroxyapatite ceramic scaffolds were
most commonly implanted [29,33,34], followed by titanium metal [31,32] and lastly by PCL polymer [30]. Two
studies used a scaffold enhanced with a bone graft [31,33]. The follow-up period ranged between 3 and 12
months. The data extraction of the included human studies is presented in Table 2.

Table 2. Data extraction of human studies.
Study

Level of
evidence
1

Study
design
RCT

Sample size

Sumida
et al.
2015

3

Clinical
trial

Park et
al. 2016

4

Shen et
al. 2014
Brie et
al. 2013

4

Saijo et
al. 2009

4

Goh et
al. 2014

4

Defect
site
Maxilla,
mandible

Application

AM

Post-extraction
ridge
preservation

MEP

13 (custommade
scaffold)
13
(commercial
scaffold)

Mandible

Guided bone
regeneration for
ridge
augmentation

Case
series

21

Calvaria

Case
series
Case
series

23

Mandible

8 (divided in
3 groups by
scaffold
design)
10

Calvaria
and nasal
bones

Case
series

6 (scaffold)
7 (no
scaffold)

Maxilla,
mandible

Scaffold
material
PCL
polymer

Material
type
Absorbable

Bone
graft
No

Followup
6
months

Success

LP

Ti metal

Non
absorbable

Yes

n/a

13/13
(100%)

Large bone
defect
reconstruction
Bone defect
reconstruction
Large bone
defect
reconstruction

LP

Ti metal

Non
absorbable

No

6-24
months

20/21
(95%)

IJP

HA
ceramic
HA
ceramic

Absorbable

No
No

23/23
(100%)
8/8
(100%)

None

Non
absorbable

3-10
months
12
months

Bone defect
reconstruction /
augmentation

IJP

HA/a-TCP
composite

Non
absorbable

No

12
months

10/10
(100%)

None

LP

6/6
(100%)

Serious
complications
Exposure 2/6
(33%)
No bone in-growth
1/6 (17%)
Experimental
group: exposure
1/13 (8%),
infection 1/13 (8%)
Control group:
exposure 3/13
(23%), infection
3/13 (23%)
Infection 1/21 (5%)

None

Abbreviations: additive manufacturing (AM), inkjet printing (IJP), laser printing (LP), micro-extrusion printing (MEP), polycaprolactone (PCL), titanium
(Ti), hydroxyapatite (HA).

4.3. Risk of bias within studies

The risk of bias of the included randomized and non-randomized clinical trials can be seen in Table 3, Table
4 respectively. According to the Cochrane risk of bias tool, the one identified randomized control trial [30] was
evaluated as having high risk of bias. Although allocation concealment (sealed envelopes) was applied, no
information was given regarding random sequence generation. It is unclear if the participants and personnel
were blinded. As far as the assessors are concerned, no blinding is mentioned for all means of outcome
evaluation, except for radiographic grading. Multiple outcome measurements raise some concerns for other
sources of bias. According to the ROBINS-I tool, the one identified non-randomized trial [31] was evaluated as
having serious risk of bias. Confounding parameters were not adjusted, the classification of intervention was not
well defined and the assessors were aware of the intervention received by the study participants.

Table 3. Risk of bias assessment of identified randomized control trials (RCTs).
AUTHOR

OUTCOMES

Sequence
generation

Allocation
concealment

Performance
bias

Detection bias

Attrition
bias

Selective
reporting

Goh et
al.
2014

Alveolar ridge
height/width
(evaluation of
bone
resorption)

Unclear
(not possible to
conclude if
randomization
was successful)

Low risk
(sealed
envelopes)

Unclear
(no information
provided;
blinding of
participants/
personnel is not
easily possible)

High risk
(no blinding
mentioned for
all aspects of
analyses;
outcome is
objective and
blinding is
feasible)

Low risk
(one patient
drop-out
reported;
unlikely to
result in
imbalance)

Low risk
(all reported
results
correspond
to intended
outcome)

Other
sources of
bias
Unclear
(residual
bias
cannot be
excluded)

Overall Bias
High risk of
bias
(the study is
judged to be
at high risk of
bias in at
least one
domain for
this outcome)

Table 4. Risk of bias assessment of identified non-randomized trials.
AUTHOR

OUTCOMES

Bias due to
confounding

Sumida
et al.
2015

1.postoperative
infection
2.operative
time
3.mucosal
rupture
4.number of
fixation screws

Serious risk
(reliability or
validity of
measurements of
an important
domain was low
enough that we
expect serious
residual
confounding)

Bias in
selection of
participants
into the study
Low risk
(all participants
eligible for
target trial
were included
in the study,
start of followup and start of
intervention
coincided

Bias in
classification
of
intervention
Serious risk
(intervention
status is not
well defined)

Bias due to
deviations
from intended
interventions
Low risk
(any deviations
from usual
practice were
unlikely to
impact on the
outcome)

Bias due to
missing
data

Bias in
measurement of
outcomes

Low risk
(data were
reasonably
complete)

Serious risk
(The outcome
measure was
objective, but
the assessors
were aware of
the intervention
received by study
participants)

Bias in
selection of
reported
result
Low risk
(all reported
results
correspond
to all
intended
outcomes)

Overall
Bias
Serious
risk
of bias
(the study
is judged
to be at
serious
risk of
bias in at
least one
domain)

Because of the heterogeneity of the research methods and the intervention characteristics as well as the high
risk of bias of studies, only qualitative analysis of the data of the included studies was performed. Metaanalysis was not feasible.

4.4. Outcomes evaluation

The immediate and long-term bone repair was successful for the time of observation and only one study
reported failure of one case [32]. Regarding serious complications, three studies reported infection and/or
exposure of the biomaterial, and fibrous invasion of the scaffold instead of bone infiltration [[30], [31], [32]].
Nevertheless, all the authors stated that these complications were successfully managed and in no case was the
sustainability of scaffold affected.

5. Animal studies
5.1. Study selection

The 36 included animal studies were published in scientific journals in English, during the period 2007–2017
[[35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56
], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71]]. One study was published as
poster presentation [72].

5.2. Study characteristics

Overall, the studies included 614 animal subjects. Each study included one to 68 animals; with only one study
[53] not reporting the number of the animals used. Rabbits were most commonly used
[40,41,49,50,[54], [55], [56],59,60,62,[68], [69], [70],72], followed by rats [52,53,57,61,62,[64], [65], [66]], mice
[39,44,45,48,58,67], pigs [36,46,47,51], sheep [35,37,42,63] and dogs [38,71].
The vast majority of the defects were calvarial
[35,37,[39], [40], [41], [42],[44], [45], [46], [47], [48], [49], [50],[52], [53], [54], [55], [56], [57], [58], [59], [60], [61
], [62],[64], [65], [66], [67],69,73], followed by mandibular [38,51,57,63,68,70,71] and maxillary [36] ones.
Microextrusion was most commonly used
[[36], [37], [38],42,44,46,47,49,[53], [54], [55],61,64,66,67,[69], [70], [71], [72]], followed by inkjet printing
[39,45,50,56,[58], [59], [60],62,65] and laser printing [35,40,41,48,52,57,68]. Most studies used degradable
biomaterials, with only two exceptions [35,68]. Hydroxyapatite and tricalcium phosphate scaffolds and/or
composites were most commonly implanted
[[36], [37], [38],42,44,47,48,51,[53], [54], [55], [56], [57],59,60,62,64,65,67,[69], [70], [71], [72]]. In
approximately half of the studies, the scaffold was enhanced with biomolecules, such as BMP-2 and/or stem
cells [35,36,39,40,42,[44], [45], [46], [47],[51], [52], [53], [54],57,58,[65], [66], [67], [68]]. Three studies
implanted non-3D printed dermal matrices, enhanced with 3D printed biomolecules [39,45,58]. The total time of
observation, of the included animal studies ranges from 4 to 26 weeks. The data extraction of included animal
studies is presented in Table 5.

Table 5. Data extraction of animal studies.
Author

Animal

n

Defect origin

AM

Scaffold material

Cooper et al. 2010

Mouse

68

Calvaria

IJP

Herberg et al. 2014

Mouse

19

Calvaria

IJP

Ishack et al. 2015
Keriquel et al. 2010

Mouse
Mouse

15
30

Calvaria
Calvaria

MEP
LP

dermal matrix (non 3D
printed)
dermal matrix (non 3D
printed)
HA/β-TCP composite
n-HA ceramic

Biomolecules & cell
seeding
BMP-2 (3D printed
injection)
BMP-2, SDF-1β, TGF-β1 (3D
printed injection)
Dipyridamole, BMP-2
–

Time of
observation
4 and 8 wks

Serious
complications
None

4 wks

None

2, 4 and 8 wks
1 and 2 wks, 1 and
3 months
2, 3, 4, 5, 6, 7 and
8 wks
4 wks

None
None

Li/Xu et al. 2016

Mouse

42

Calvaria

MEP

PLGA/nHA composite

LV-pdgfb cells

Smith et al. 2012

Mouse

8

Calvaria

IJP

Jensen et al. 2013
Jensen et al. 2016

Pig
Pig

16
14

Calvaria
Calvaria

MEP
MEP

Dadsetan et al.
2015
Ge et al. 2009

Rabbit

10

Calvaria

LP

BMP-2 (3D printed
injection)
Mononuclear cells, BMP-2
BM stromal cells, DP
stromal cells
BMP-2

Rabbit

18

Calvaria

LP

dermal matrix (non 3D
printed)
PCL polymer
PCL polymer, HA/β-TCP
composite
PPF polymer with CP
coating
PLGA polymer

8 and 12 wks
5 wks

2 deaths (unrelated)
None

6 wks

None

–

4, 12 and 24 wks

HA/β-TCP composite
MgP ceramic
OCP ceramic
CSi–Mg6 ceramic

–
–
–
–

8 and 16 wks
4 and 8 wks
6.5 months
4, 8 and 12 wks

1 death
intraoperatively
None
None
None
None

Goetz et al. 2013
Kim et al. 2016
Komlev et al. 2015
Shao/Ke et al.
2017
Shim et al. 2014

Rabbit
Rabbit
Rabbit
Rabbit

8
40
5
24

Calvaria
Calvaria
Calvaria
Calvaria

MEP
MEP
IJP
MEP

Rabbit

36

Calvaria

MEP

BMP-2

4 and 8 wks

None

–
–
–
–
–

8 and 16 wks
8 and 16 wks
8 wks
8 wks
2 and 8 wks

None
None
None
None
None

IJP

PCL/PLGA/β-TCP
composite
HA ceramic
HA ceramic
TCP ceramic
TCP ceramic
PCL/PLGA/β-TCP
composite
PLLA/β-TCP composite

Simon et al. 2007
Simon et al. 2008
Tamimi et al. 2009
Torres et al. 2011
Hwang et al. 2017

Rabbit
Rabbit
Rabbit
Rabbit
Rat

16
16
8
8
32

Calvaria
Calvaria
Calvaria
Calvaria
Calvaria

MEP
IJP
IJP
IJP
MEP

Kwon et al. 2017

Rat

30

Calvaria

PPF/PLGA composite
PCL polymer

2, 4, 6, 8, 10 and
12 wks
11 wks
4, 8 and 12 wks

None

LP
MEP

MG-63 human
osteoblastoma cells
BMP-2, AD stem cells
Platelet-rich plasma

Lee et al. 2012
Li/Chen et al. 2017

Rat
Rat

12
24

Calvaria
Calvaria

None
None

None
None

Pati et al. 2014

Rat

N/A

Calvaria

MEP

Zhao et al. 2015
Tamimi et al. 2014

Rat
Rat,
Rabbit
Sheep

18
6,
16
1

Calvaria
Calvaria

Sheep

TM stem cells

8 wks

None

MEP
IJP

PCL/PLGA/β-TCP
composite
Sr-MBG polymer
TCP ceramic

–
–

8 wks
8 wks

None
None

Calvaria

LP

PEKK

Mesenchymal stem cells

12 wks

None

12

Calvaria

MEP

HA/α-TCP composite

–

8 and 16 wks

None

Sheep

9

Calvaria

MEP

Chitosan

14 wks

None

Rat

10

LP

Mesenchymal stem cells

10 and 30 days

None

Carrel/Wiskott et
al. 2016
Shim et al. 2017
Konopnicki et al.
2015
Rockies et al. 2017

Dog

1

Calvaria,
Mandible
Mandible

PLGA polymer, TCP/Col
composite
PDLLA/β-TCP composite

MEP

HA/α-TCP composite

–

8 wks

None

Dog
Pig

3
2

Mandible
Mandible

MEP
IJP

PCL/β-TCP composite
PCL/β-TCP composite

–
BM progenitor cells

8 wks
8 wks

None
None

Rabbit

12

Mandible

LP

PEKK

AD stem cells

10 and 20 wks

Shao/Sun et al.
2017
Ciocca et al. 2017
Abarrategi et al.
2012

Rabbit

16

Mandible

MEP

–

8 and 16 wks

Sheep
Pig

1
8

Mandible
Maxilla

n/a
MEP

TCP, CSi, CSi-Mg10,
bredigite (Bred) ceramic
PCL-HA composite
HA/β-TCP composite

1 case (exposure &
infection)
None

–
Chitosan/BMP-2

3 months
3 months

None
None

Adamzyk et al.
2016
Carrel/Moussa et
al. 2016
Haberstroh et al.
2010
Smeets et al. 2016

Abbreviations: additive manufacturing (AM), inkjet printing (IJP), laser printing (LP), micro-extrusion printing
(MEP), polycaprolactone (PCL), hydroxyapatite (HA), tricalcium phosphate (TCP), polylactide-co-glycolide acid (PLGA), magnesium phosphate (MgP),
octacalcium phosphate (OCP), calcium silicate (CSi), poly-L-lactide (PLLA), propylene fumarate (PPF), poly-D,L-lactide (PDLLA), polyetherketoneketone
(PEEK), bone morphogenetic protein (BMP), stromal cell-derived factor (SDF), transforming growth factor (TGF), dental pulp (DP), adipose-derived (AD),
turbinate tissue-derived mesenchymal (TM), bone marrow (BM).
Notes: All studies reported bone formation. All materials are degradable except for PEKK. Goetz et al.2013 is a poster presentation. Table entries sorted
by defect origin, and then by animal.

5.3. Quality assessment and risk of bias within studies

Regarding the quality assessment of the included animal studies, most of them were of moderate quality (B),
but five were graded as high (A) and nine as low quality (C). The reasons why most of the studies were graded as
moderate were because outcome assessments and scores were not blinded, sample sizes were not justified,
methods of randomization were not stated, blocking experiments were not performed or no raw data were
available (Supplementary Table 2).
As for the risk of bias, the vast majority of the animal studies were evaluated as having high risk of bias regarding
the sequence generation, the allocation concealment and the blinding parameters. On the contrary, the great
majority of the animal studies were evaluated as having low risk of bias regarding the outcome data and the
selective reporting parameters (Table 6).

Table 6. Risk of bias assessment for animal studies.
Author
Abarrategi et al.
2012
Adamzyk et al.
2016
Carrel et al.
2016a
Carrel et al.
2016b
Ciocca et al. 2017
Cooper et al.
2010
Dadsetan et al.
2015
Ge et al. 2009
Goetz et al. 2013
Haberstroh et al.
2010
Herberg et al.
2014
Hwang et al.
2017
Ishack et al. 2015
Jensen et al. 2014
Jensen et al. 2016
Keriquel et al.
2010
Kim et al. 2016
Komlev et al.
2015
Konopnichi et al.
2015
Kwon et al. 2017
Lee et al. 2013
Li et al. 2016
Li et al. 2017

Adequate
sequence
generation
–

Risk of
bias

Allocation
concealment

Risk of
bias

Blinding

Risk of
bias

Risk of
bias

Free from selective
reporting

Risk of
bias

H

Incomplete
outcome
data addressed
+

H

–

H

–

H

+

L

–

H

–

H

+

L

–

L

+

L

+

L

–

H

–

H

+

H

+

L

–

H

–

H

–

H

–

L

+

L

–
–

H
H

–
–

H
H

–
–

H
H

–
–

L
L

+
+

L
L

–

H

–

H

–

H

–

L

+

L

–
–
+

H
H
L

–
–
–

H
H
H

–
–
–

H
H
H

+
+
–

H
H
L

–
–
+

H
H
L

+

L

–

H

–

H

–

L

+

L

–

H

–

H

–

H

+

H

+

L

–
+
+
–

H
L
L
H

–
–
–
–

H
H
H
H

–
–
+
–

H
H
L
H

–
–
–
+

L
L
L
H

+
+
+
+

L
L
L
L

–
–

H
H

–
–

H
H

–
–

H
H

–
–

L
L

+
+

L
L

–

H

–

H

–

H

–

L

+

L

–
–
+
–

H
H
L
H

–
–
–
–

H
H
H
H

–
–
–
–

H
H
H
H

–
–
+
–

L
L
H
L

+
+
+
+

L
L
L
L

Pati et al. 2014
Roskies et al.
2017
Shao et al. 2017a
Shao et al. 2017b
Shim et al. 2014
Shim et al. 2017
Simon et al.
2017a
Simon et al.
2017b
Smeets et al.
2016
Smith et al. 2012
Tamimi et al.
2009
Tamimi et al.
2014
Torres et al. 2011
Zhao et al. 2015

+
–

L
H

–
–

H
H

–
–

H
H

–
+

L
H

+
+

L
L

+
–
+
+
–

L
H
L
L
H

–
–
–
–
–

H
H
H
H
H

–
–
–
–
–

H
H
H
H
H

+
–
–
–
+

H
L
L
L
H

+
+
+
+
+

L
L
L
L
L

–

H

–

H

–

H

–

L

+

L

–

H

–

H

–

H

–

L

+

L

–
–

H
H

–
–

H
H

–
–

H
H

+
–

H
L

+
+

L
L

–

H

–

H

–

H

–

L

+

L

+
+

L
L

–
–

H
H

–
–

H
H

–
–

L
L

+
+

L
L

Abbreviations: YES (+), NO (-), high (H), low (L).

5.4. Outcomes evaluation

The immediate and long-term bone repair was successful for the time of observation among animal studies
demonstrated by histological, biochemical, histomorphometric or microcomputed tomographic findings.
However, some studies reported only bone formation along the scaffold structure and not inside. Only two
studies exhibited complications, related to scaffolds; one incidence of surgical complications [41], one incidence
of minor exposure and infection [68].

6. Discussion
6.1. Overview of existing studies

The present systematic review included only in-vivo studies in order to evaluate the application of the 3D
printed scaffolds in live subjects. For better understanding of these strategies both human and animal studies
were included. The systematic search, based on the inclusion criteria, yielded a limited number of human
studies and a greater number of animal studies. It was decided to include animal studies in the review, since
clinical application of 3D-printing in humans is still scarce in the literature. The human studies reported high
success with limited serious complications, but they were all evaluated as having high risk of bias; the quality
assessment revealed that none fulfilled the requirements of a high-quality study design. Nevertheless, these
studies provide valuable findings for a cutting-edge technology, applied on human beings. On the other hand,
animal studies provide a bridge between in-vitro and human studies, by illustrating significant parameters of the
histological and cellular background of scaffold integration and bone regeneration, even though the quality of
these studies is regarded as moderate. Nevertheless, within limitations and concerns of assessing animal studies
and relating such findings to applications in human beings, it needs to be acknowledged that animal studies
constitute a first in-vivo level of evidence.

6.2. Scaffold materials & combinations

Many types of scaffold materials, alone or combined, have been proposed in an attempted to integrate many
desirable properties, such as osteoinductivity, osteoconductivity, printability, biocompatibility and durability
[6,9].
Bioceramics are the materials most commonly selected. Calcium phosphate compounds (mainly β-TCP) exhibit
favorable biodegradability, chemical bonding with hard tissues and wear resistance, all necessary for loadbearing craniofacial defect sites [74]. The challenge is to maintain a low temperature of sintering in an attempt
to avoid transformation of β-TCP to α-TCP, which is more chemically unstable [75]. In addition, HA has been
deemed a scaffold material for bone repair with outstanding biocompatibility, because of the stoichiometric
similarity to the mineral phase of natural bone [76]. However, it is frequently combined with other bioceramics
or biopolymers due to its inherent weak interaction with the binder liquid during 3D printing process
[77]. Bioglasses are also used, because they show great osteoconductivity and bonding to hard tissue,
nevertheless, they slowly degrade and provoke cytotoxicity on the surrounding tissue [78]. Their major
advantage is that they upregulate osteogenesis and nicely interact with cells [30,31], but they are too brittle for
implantation in load-bearing craniofacial sites [2]. A human study of our review confirms this disadvantage. Saijo
et al. [33] used HA/a-TCP composite scaffolds for maxillomandibular defects and emphasized the difficulties of
composition and fabrication of an ideal scaffold to fulfill strength and dimensional requirements.
Biopolymers have also been widely used. Alginate is usually chosen for cartilage repair, because it
induces chondrocyte proliferation and is compatible with cartilaginous tissue [79,80]. However, it does not
interact with cells and is not suitable for load-bearing applications due to its very low stiffness [11,81].
Biogenic polyphosphates (bio-polyP), such as PCL and PLGA, have remarkable printing resolutions and porosity,
biocompatibility and osteoconductivity [82,83]. Biogenic silica is another biopolymer which is highly

osteoproductive in unfavorable environmental conditions and ensures effective nutrient diffusion in hard
craniofacial tissues with moderate vascularity. It is suitable for cell and proteins adhesion [84,85]. In general, the
superiority of biopolymers over other materials is their prime printability and their ability to efficiently promote
osteogenesis in the scaffold complex.
Metal applications are predominately by titanium. It has incredible biocompatibility and mechanical properties,
such as elastic modulus, fatigue strength and toughness; features which are comparable with natural bone
[86,87]. It is preferable for craniofacial vault reconstruction, where the size of the defect is extensive. It nicely
redefines the shape and aesthetic condition of the affected site. Although non-absorbable, it has the potential
for bone ingrowth, when 3D printed Ti plates incorporate porosity in the periphery, or if 3D printed Ti meshes
have been added to preserve bone grafts [88]. Up to now, the AM technology focused on using ceramics or
polymers for bone tissue engineering, the 3D printing of titanium in microscale has posed considerable
challenges [86].
Composites are the combination of bioceramics with biopolymers to achieve the desirable properties; no single
biomaterial is able to satisfy all the prerequisites for a bone graft material. Composite materials incorporate the
characteristics of their components (e.g. the high wear resistance of ceramics and high toughness of polymers)
[2]. Calcium phosphate/collagen, hydroxyapatite/polyamide, TCP/HA/polyP and others have been proposed for
better chemical and mechanical properties [89,90] as well as controlled porosity and cell interaction [91]. These
materials have been introduced for craniofacial application [92].

6.3. Growth factors & cells

Two strategies have been followed to incorporate biomolecules and cells in scaffolding structures. One method
is to print acellular scaffolds and then seed them with cells through chemical binding. The suitable binder (e.g.
phosphoric acid) should prevent pH-related damage of seeded cells. Alternatively, in bioprinting, the scaffold
material and cells are printed simultaneously. This latter method is superior in precise cell distribution into the
scaffold, however it suffers from low mechanical strength (5 kPa) and temperature- and pressure-related
damage to the cells during printing. These are the main reasons that bioprinting has not yet been used for
human craniofacial tissue regeneration; instead, the method of acellular printing and subsequent cell seeding
seems to be the preferable choice [1]. Cell proliferation should follow a balanced momentum; the viability of the
scaffold can be influenced by insufficient proliferation, whereas too much proliferation can
evoke hyperplasia and apoptosis. Long-term survival and controlled proliferation of cells are essential to achieve
tissue homeostasis of the newly formed bone [6].
Understandably, animal studies have tested a greater variety of materials, alone or in combination with
biomolecules and seeding cells (stem or progenitor cells), scaffolding innovations which have not been
adequately studied in humans. The animal studies show that there is a positive interaction between the scaffold
material and the biomolecules/cells [40,45,47,51]. Noteworthy, the biomolecules/cells can be incorporated in
material rods during layering and not only after microporous fabrication [48]. There is a synergetic stimulation
of bone formation in the scaffolding area through the osteoconductive properties of some scaffold materials
and the osteoinductive properties of the seeding cells [41,42,44,53,67]. Factors, such as TGFβ, BMP-2, MSCs,
BMCs, Chitosan and stromal cells, promote osteogenesis by inducing cell transform towards the bone cell
lineage. Leaving sufficient time for cell cultivation (1–2 weeks) is essential to create a
favorable microenvironment before scaffold implantation [51].

6.4. Capabilities of 3D printing techniques

The in-depth knowledge of 3D printers’ capabilities and their compatibility with scaffolding materials lays the
groundwork for successful application of 3D printing in human and animal subjects. Inkjet printers have high

print speed, low cost, high resolution and compatibility with many biological materials and cells [2]. Also,
printing can be with noncontact and overprinting can be achieved [39]. Nevertheless, some disadvantages, such
as nozzle clogging, alteration of cell viability, uncontrolled droplet size and directionality, should be taken into
account. This type of printer is suitable for low viscosity materials in liquid form and low cell concentrations [93].
Laser printers lack a nozzle, and therefore, the problem of material/cell clogging is avoided [11]. They are
compatible with materials with high range of viscosity, do not have a detrimental effect on cell viability and
achieve high resolution, although at a high cost and a low flow rate [16,94]. The micro-extrusion method is
suitable for bioprinting of a broad array of materials and has the ability to deposit very high cell densities [6].
However, cell viability is lower than the other two types of bioprinting and printing resolution, as well as printing
speed, is often problematic [95].

6.5. Scaffold kinetics & biocompatibility

A controllable degradation rate of the scaffold is required. Ideally, this rate should match the ability of the cells
to replace the biomaterials with their own extracellular matrix (ECM) through a mechanism in which embedded
cells secrete proteases and subsequently produce ECM proteins that define the new tissue [6]. It is also
challenging to have control over degradation byproducts, the whole process should be nontoxic and the
degradation products should rapidly metabolize without producing a detrimental environment to cell viability
and function. The swelling and shrinkage of the biomaterial can unfavorably affect the success of the scaffold,
evoking contamination and inflammation at defect boundaries as well as immune system reaction. Besides this,
biocompatibility should be considered not only as the means to prevent local/systemic effects, but also the
scaffold should have the ability to actively contribute to all biological and functional aspects [96].
The animal studies that use absorbable materials confirm and augment the above findings. Attempts to
fabricate scaffolds that biodegrade in rates comparable to autologous block grafts [38,97] have shown that it is
difficult to duplicate the regenerative ability of native bone (it differs between bones; i.e. ilium has more blood
supply and osteoprogenitors than others) and match degradation of the biomaterial with new bone apposition
[59]. Mostly the higher porosity facilitates more rapid biodegradation [49]. This issue becomes even more
difficult, since the fact that degradation kinetics and mechanical properties are irreversibly proportional (faster
degradation, lower mechanical strength) [44,57]. The high rate ensures fast bone turnover, avoids any
inflammatory process and protects from fibro gingival dehiscence and invasion [57]. On the other hand, scaffold
coverage should be performed without soft tissue tension (the block edges should be rounded) to avoid
exposure and unnecessary degradation by macrophages and osteoclasts [38]. Also, the degradation rate should
not be too fast, but in a physiological rate, to encourage more tissue penetration as well as nutrient exchange
without affecting the scaffold stability [41,42,52].

6.6. Structural scaffold design & mechanical properties

Several parameters of scaffold design are important to fulfill bone in-growth. Regarding the scaffold macrogeometry, the scaffold should precisely fit in the bone defect without having a complicated outline, otherwise it
may not yield to 3D printing [6]. The micro-architecture of the scaffold should be well-structured and with
sufficient porosity and interconnectivity for bone in-growth, cell transportation and nutrient diffusion [11]. The
scaffold should be bioactive by incorporation of mineral phases for osteoinductivity (chemical binders to create
a mineralized structure that can house cells) [1]. Moreover, mechanical properties should be analogous of native
bone. The selection of the biomaterial is driven by the size and load-bearing demands of the affected site.
Human bone exhibits a wide range of physical properties; for example, the human trabecular bone within the
condyle has an elastic modulus ranging between 120–450 MPa and within the mandibular body ranging
between 112–910 MPa [10]. Unfortunately, many 3D printed scaffolds range much lower than these
requirements (10–100 MPa) and we believe that this is the main reason for limited reports of applications in
load-bearing sites.

Perhaps, this is the reason that most of the studies used predominately 3D printed applications in calvaria. In
humans, the case series by Brie et al. [34] compared three hydroxyapatite (HA) ceramic scaffolds, the first
scaffold type was not perfectly adapted to the defect, the second type was perfectly adapted to the defect and
the third had additional peripheral macro-porous areas. They concluded that the hydroxyapatite implants are
well suited to reconstruct large (greater than 25 cm2) or complex calvarial or front-orbital defects, as these
scaffolds eliminate the necessity of bone grafting and facilitate bone reconstruction, giving external shape and
internal porosity. Nevertheless, mimicking the 3D complexity of natural tissues and functionally integrating the
scaffold in bone defects represent significant challenges to which the authors answered with a scaffold with
dense core for mechanical strength and peripheral porosity for bone integration. The case series by Park et al.
[32] used Ti metal scaffolds for calvarial defects with a honeycomb structure to raise the strength-to-weight
ratio. These scaffolds were considered the perfect choice for rehabilitation of large size defects, where the large
amount of required autologous bone affects donor morbidity.
The animal studies emphasized that 3D printing controls the external and the internal architecture of the
material and the scaffold acts as a template for cell colonization and extracellular matrix formation
[36,47,50,52]. External surface topography should be rough enough to increase surface ground for cell
attachment and proliferation as well as to firmly consolidate with the adjustment native bone [35,36,38,63].
Moreover, external surface should act as a barrier for fibrous tissue invasion, since that is a major factor of
scaffold failure [41,46,48]; another way to avoid that is to cover the scaffold with a membrane [38,53,54,64].
Open channels in the periphery of the scaffold increase the migration of osteogenic factors [56]. The internal
surface should be porous enough to facilitate penetration of bone agents and vessels into the scaffold, but to an
extent that the mechanical resistance is not affected [40,71]. It is the fundamentals of 3D printing that
constitute scaffolds as linear porous structures which are controllable in size and patency over the entire length
of the blocks [41,65,66]. These structures are superior to particulate materials, since 3D scaffold provides a
stable environment for multi-level bone augmentation and an organized arrangement of channels/pores for the
progression of a “mineralization front” with its accompanying vascular system [37,51,54,55]. Dead-ends of tubes
and channels increase the concentration of osteogenic factors [56].
Almost all researchers of animal studies pointed out two critical features of scaffold material, important for
scaffold survival. The first one is their porosity (pore size, pore morphology, pore interconnectivity and
distribution) [41,46,49,56,63,72,98]. Most studies conclude that the pores size of scaffolds should be 100–
500 μm to steer the migration/proliferation/differentiation of mesenchymal stem cells, supply with
oxygen/nutrients and to induce the diffusion of factors that trigger inner bone formation [35,37,42,46]. Pore size
below 100 μm promotes chondrogenesis and subsequently ossification, whereas pore size above 100 μm
stimulates direct ossification, but to a size (∼500 μm) that the durability of scaffold is not affected [98]. Very
small size of pores hinders cellular ingrowth and evokes a foreign body response [46]. The second feature
related to scaffold survival is the ability to withstand physical forces. This is an important property when
considering replacement of load-bearing bone and critical-sized defects [61,68,70]. Mechanical strength
depends on the chemical composition, size, shape, surface modification and porosity of the scaffold
[40,47,52,68,69]. Mechanical strength of bone can vary even for the same bone, depending on gender, age and
health condition of the body [98].

6.7. 3D printing applications & topography of bone regeneration

3D printing technology in the craniofacial region has three main application areas: a) rehabilitation of a defect
site with a custom-made prosthesis to restore normal facial appearance, in cases of large bone or soft tissue
defects after trauma and tumor ablation. b) for reconstruction purposes, 3D models, fixation devices, cutting
guides and implanted medical devices can be printed to facilitate and optimize surgical intervention by creating
the essential framework and primary stability for bone grafts. This application is beyond the scope of this

review. c)regeneration aiming to preserve existing bone and stimulate osteogenesis for ultimate bone repair and
normal anatomic and functional restoration [1,11]; this application is still at an initial stage of research. The
researchers seem to emphasize the regeneration potential of the scaffolds, without present long-term follow-up
of scaffold degradation/bone regeneration or in-depth investigation of their clinical sustainability.
The only randomized clinical trial by Goh et al. [30], used polycaprolactone (PCL) polymer scaffold, developed by
a micro-extrusion 3D printer, to preserve maxillary and mandibular alveolar ridge height after tooth extraction in
preparation for final implant restoration, and compared two groups, with or without scaffold. However, the
sample size was too small and underpowered. Bone resorption was noted as evident in both groups, but the
insertion of the 3D bioresorbable scaffold in fresh extraction sockets allowed normal bone healing and better
ridge height maintenance mainly at the mesio-buccal aspect after 6 months as compared to the control group
without the insertion of a scaffold. Nevertheless, the material had not actually resorbed during these months
and that may be the reason for maintenance of alveolar ridge. Interestingly, they suggested the combination of
PCL- tricalcium phosphate (TCP) for favorable degradation and resorption kinetics than PCL alone, without
blocking new bone ingrowth. The positive results of bone formation in animals should be evaluated with
caution, since there are studies which report predominately superficial or irregular bone formation and no or
less bone distribution in the inner structure [38,41,60,62]. The most bone formation was noted at the
interproximal surface of scaffold to adjacent bone [40] and progressively less bone towards the center of the
structure [49,50,55]. However, more bone formation in depth may be expected over time [56,66]. In addition,
the defect geometry plays an important role to successful bone ingrowth; it is preferable to have extensive
surface connection with native bone and thereby proximity with osteoprogenitors [58,59]. The quality of formed
bone seems to be very good with trabecular- and marrow-like structures [49,55,72]. Interestingly, some studies
report that the critical degree of bone filling in the defect area for placement of a dental implant is less than
optimal volume (100%) and the studies report 40–60% of bone filling as adequate for support of a dental
implant [59,62,99,100].

6.8. Operative manipulation & complications

3D printed technology enables the meticulous study, design, fabrication and surgical position of the
scaffold/implant. Virtual planning and fewer surgical steps can be achieved, minimizing operative
and postsurgical complications [101]. The combined findings in human studies illustrate that 3D scanning
technology provides the specific shape of the craniofacial surface and 3D printing accurately replicates the
defect. Surgical maneuvers are easier and operative time is less. The implants can obtain detailed surface design
that enhances the strength-to-weight ratio, tissue integration and bone ingrowth, resulting in high durability,
aesthetics and low inflammatory rate. Dentoalveolar defects require a rapidly resorbing matrix to avoid wound
dehiscence, exposure, and subsequent microbial contamination.
The non-randomized trial by Sumida et al. [31] compared custom-made to prefabricated Ti scaffolds for guided
bone regeneration of mandibular sites for dental implants. Their findings agree with other studies [35,102], in
that the 3D-printed custom-made scaffolds have more ideal shape, better surgical handling, and considerably
less intraoperative time, eliminating postoperative infections and mucosal rupture. The accuracy of the
fabrication procedure leads to improved functional and aesthetic results [103]. The case series by Park et al. [32]
used Ti metal scaffolds for calvarial defects and highlighted the advantages of perfect anatomic alignment and
aesthetic result, shorter operating time and lower risk of infection due to reduced manipulation. Shen et al. [29]
used absorbable HA ceramic scaffolds in mandibular defects after mandibular angle osteotomy and pointed out
the same benefits; the accuracy of the 3D structure ensures successful replacement of the defect, saving
operative time and stimulating postoperative recovery.

6.9. Strength & limitation of the present review

The strengths of the current systematic review include the comprehensive literature search including grey
literature, the robust use of methods for qualitative synthesis and the open provision of the review’s dataset as
an attempt to increase transparency and reproducibility. No language restrictions were applied to avoid
language bias. No publication status or year restriction was applied, thereby maximizing data yield. By including
both human and animal studies, the pool of human studies was enhanced with animal studies, as an effort to
collect information for a recent clinical approach and ongoing technology. Though no unanimously accepted
method for quality assessment of animal studies is available, broad but clinically relevant eligibility criteria were
carefully set in this review to include studies that examined various combinations of biomaterials and types of
3D printing.
Several limitations of the study should be noted. Due to scarcity of randomized and prospective non-randomized
studies, several retrospective case studies were included. Uncontrolled studies with methodological limitations
were part of the review. On the other hand, case series with fewer than five participants which were excluded to
avoid low quality evidence may have interesting findings. Another limitation is that the type and number of
animals as well as the time of observation vary among studies, giving great heterogeneity in many domains.

6.10. 3D printing: Current facts & prospects

The application of 3D printing technology for tissue engineering is not yet universally accepted. 3D printing
strategies on bone repair, especially in the regeneration field, seems to have many obstacles to overcome. In
our mind, ongoing research will overcome surgical difficulties, material manipulation and potential criticisms of
the use of certain regenerative biomolecules in humans. The fabrication of 3D printed scaffolds should be
considered as a promising alternative for bone tissue repair in craniofacial deficiency on the supposition that
several parameters should be taken into account to ensure the success and wide-spread application of 3D
printing bone scaffolding. Firstly, an important factor is the collaboration between medical and engineering
experts, and familiarization with 3D bioengineering abilities. Secondly, the printing devices should scale up to be
faster with high resolution, compatible with biomaterials/living cells and affordable price; nevertheless, the
necessary equipment is expected to have lower cost over the years. Thirdly, the science of biomaterials should
produce compounds in optimal combinations to achieve the desired functional, mechanical and supportive
properties. Direct control over cell proliferation and differentiation as well as well-characterized and
reproducible source of cells are required. Scaffolds should be developed to actively induce vascularization,
innervations, replacement by bone and bone maturation; not just be inert structures. Lastly, human research
should focus on high quality clinical trials, which will provide evidence to assess 3D printing scaffolds over
conventional grafting strategies.

Acknowledgements
None.

References

[1] E.L. Nyberg, A.L. Farris, B.P. Hung, M. Dias, J.R. Garcia, A.H. Dorafshar, W.L. Grayson. 3D-printing
technologies for craniofacial rehabilitation, reconstruction, and regeneration. Ann. Biomed.
Eng., 45 (1) (2017), pp. 45-57
[2] M.D. Fahmy, H.E. Jazayeri, M. Razavi, R. Masri, L. Tayebi. Three-dimensional bioprinting materials with
potential application in preprosthetic surgery. J. Prosthodont., 25 (4) (2016), pp. 310-318
[3] J.L. Ricci, E.A. Clark, A. Murriky, J.E. Smay. Three-dimensional printing of bone repair and replacement
materials: impact on craniofacial surgery. J. Craniofac. Surg., 23 (1) (2012), pp. 304-308

[4] C.W. Hull. Apparatus for production of three-dimensional objects by stereolithography. Google
Patents (1986)
[5] J.P. Kruth. Material incress manufacturing by rapid prototyping techniques. CIRP Ann. Manuf.
Technol., 40 (2) (1991), pp. 603-614
[6] S.V. Murphy, A. Atala. 3D bioprinting of tissues and organs. Nat. Biotechnol., 32 (8) (2014), pp. 773-785
[7] M. Nakamura, S. Iwanaga, C. Henmi, K. Arai, Y. Nishiyama. Biomatrices and biomaterials for future
developments of bioprinting and biofabrication. Biofabrication, 2 (1) (2010), Article 014110
[8] T.J. Horn, O.L. Harrysson. Overview of current additive manufacturing technologies and selected
applications. Sci. Prog., 95 (Pt 3) (2012), pp. 255-282
[9] J.L. Moreau, J.F. Caccamese, D.P. Coletti, J.J. Sauk, J.P. Fisher. Tissue engineering solutions for cleft palates.
J. Oral Maxillofac. Surg., 65 (12) (2007), pp. 2503-2511
[10] S.J. Hollister. Porous scaffold design for tissue engineering. Nat. Mater., 4 (7) (2005), pp. 518-524
[11] F. Obregon, C. Vaquette, S. Ivanovski, D.W. Hutmacher, L.E. Bertassoni. Three-dimensional bioprinting for
regenerative dentistry and craniofacial tissue engineering. J. Dent. Res., 94 (9 Suppl) (2015), pp. 143S152S
[12] R.E. Saunders, J.E. Gough, B. Derby. Delivery of human fibroblast cells by piezoelectric drop-on-demand
inkjet printing. Biomaterials, 29 (2) (2008), pp. 193-203
[13] X. Cui, T. Boland, D.D. D’Lima, M.K. Lotz. Thermal inkjet printing in tissue engineering and regenerative
medicine. Recent Pat. Drug Deliv. Formul., 6 (2) (2012), pp. 149-155
[14] T. Xu, J. Jin, C. Gregory, J.J. Hickman, T. Boland. Inkjet printing of viable mammalian cells.
Biomaterials, 26 (1) (2005), pp. 93-99
[15] Y. Fang, J.P. Frampton, S. Raghavan, R. Sabahi-Kaviani, G. Luker, C.X. Deng, S. Takayama. Rapid generation
of multiplexed cell cocultures using acoustic droplet ejection followed by aqueous two-phase
exclusion patterning. Tissue Eng. Part C Methods, 18 (9) (2012), pp. 647-657
[16]B. Guillotin, A. Souquet, S. Catros, M. Duocastella, B. Pippenger, S. Bellance, R. Bareille, M. Remy, L. Bordena
ve, J. Amedee, F. Guillemot. Laser assisted bioprinting of engineered tissue with high cell density and
microscale organization. Biomaterials, 31 (28) (2010), pp. 7250-7256
[17] S.M. Peltola, F.P. Melchels, D.W. Grijpma, M. Kellomaki. A review of rapid prototyping techniques for
tissue engineering purposes. Ann. Med., 40 (4) (2008), pp. 268-280
[18] I.T. Ozbolat, M. Hospodiuk. Current advances and future perspectives in extrusion-based bioprinting.
Biomaterials, 76 (2016), pp. 321-343
[19] S. Khalil, W. Sun. Biopolymer deposition for freeform fabrication of hydrogel tissue constructs. Mater. Sci.
Eng. C, 27 (3) (2007), pp. 469-478
[20] I. Zein, D.W. Hutmacher, K.C. Tan, S.H. Teoh. Fused deposition modeling of novel scaffold architectures for
tissue engineering applications. Biomaterials, 23 (4) (2002), pp. 1169-1185
[21] J.Pa.G. Higgins, S. Cochrane. Handbook for Systematic Reviews of Interventaion Version 5.1.0.. The
Cochrane Collaboration (2011)
[22] D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. J. Clin. Epidemiol., 62 (10) (2009), pp. 1006-1012
[23] Oxford Centre for Evidence-based Medicine. Levels of Evidence. Univ Oxford (2009), pp. 4-5.
www.cebm.net)
[24]J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, J. Savovic, K.F. Schulz, L. Weeks, J.A.
Sterne. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.
BMJ, 343 (2011), p. d5928ss
[25]J.A. Sterne, M.A. Hernan, B.C. Reeves, J. Savovic, N.D. Berkman, M. Viswanathan, D. Henry, D.G. Altman, M.T
. Ansari, I. Boutron, J.R. Carpenter, A.W. Chan, R. Churchill, J.J. Deeks, A. Hrobjartsson, J. Kirkham, P. Juni
, Y.K. Loke, T.D. Pigott, C.R. Ramsay, D. Regidor, H.R. Rothstein, L. Sandhu, P.L. Santaguida, H.J. Schunem
ann, B. Shea, I. Shrier, P. Tugwell, L. Turner, J.C. Valentine, H. Waddington, E. Waters, G.A. Wells, P.F. Wh
iting, J.P. Higgins. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of
interventions. BMJ, 355 (2016), p. i4919

[26] C. Kilkenny, W.J. Browne, I.C. Cuthill, M. Emerson, D.G. Altman. Improving bioscience research reporting:
the ARRIVE guidelines for reporting animal research. PLoS Biol., 8 (6) (2010). e1000412
[27] C. Kilkenny, N. Parsons, E. Kadyszewski, M.F. Festing, I.C. Cuthill, D. Fry, J. Hutton, D.G. Altman. Survey of
the quality of experimental design, statistical analysis and reporting of research using animals. PLoS
One, 4 (11) (2009), p. e7824
[28] A.M. Liem, E.J. Hoogeveen, J. Jansma, Y. Ren. Surgically facilitated experimental movement of teeth:
systematic review. Br. J. Oral Maxillofac. Surg., 53 (6) (2015), pp. 491-506
[29] C. Shen, Y. Zhang, Q. Li, M. Zhu, Y. Hou, M. Qu, Y. Xu, G. Chai. [Application of three-dimensional printing
technique in artificial bone fabrication for bone defect after mandibular angle ostectomy]. Zhongguo
Xiu Fu Chong Jian Wai Ke Za Zhi, 28 (3) (2014), pp. 300-303
[30] B.T. Goh, L.Y. Teh, D.B. Tan, Z. Zhang, S.H. Teoh. Novel 3D polycaprolactone scaffold for ridge preservation-a pilot randomised controlled clinical trial. Clin. Oral Implants Res., 26 (3) (2015), pp. 271-277
[31]T. Sumida, N. Otawa, Y.U. Kamata, S. Kamakura, T. Mtsushita, H. Kitagaki, S. Mori, K. Sasaki, S. Fujibayashi, M
. Takemoto, A. Yamaguchi, T. Sohmura, T. Nakamura, Y. Mori. Custom-made titanium devices as
membranes for bone augmentation in implant treatment: clinical application and the comparison
with conventional titanium mesh. J. Craniomaxillofac. Surg., 43 (10) (2015), pp. 2183-2188
[32] E.K. Park, J.Y. Lim, I.S. Yun, J.S. Kim, S.H. Woo, D.S. Kim, K.W. Shim. Cranioplasty enhanced by threedimensional printing: custom-made three-dimensional-Printed titanium implants for skull defects. J.
Craniofac. Surg., 27 (4) (2016), pp. 943-949
[33]H. Saijo, K. Igawa, Y. Kanno, Y. Mori, K. Kondo, K. Shimizu, S. Suzuki, D. Chikazu, M. Iino, M. Anzai, N. Sasaki,
U.I. Chung, T. Takato. Maxillofacial reconstruction using custom-made artificial bones fabricated by
inkjet printing technology. J. Artif. Organs, 12 (3) (2009), pp. 200-205
[34] J. Brie, T. Chartier, C. Chaput, C. Delage, B. Pradeau, F. Caire, M.P. Boncoeur, J.J. Moreau. A new custom
made bioceramic implant for the repair of large and complex craniofacial bone defects. J.
Craniomaxillofac. Surg., 41 (5) (2013), pp. 403-407
[35] C. Adamzyk, P. Kachel, M. Hoss, F. Gremse, A. Modabber, F. Holzle, R. Tolba, S. Neuss, B. Lethaus. Bone
tissue engineering using polyetherketoneketone scaffolds combined with autologous mesenchymal
stem cells in a sheep calvarial defect model. J. Craniomaxillofac. Surg., 44 (8) (2016), pp. 985-994
[36] A. Abarrategi, C. Moreno-Vicente, F.J. Martinez-Vazquez, A. Civantos, V. Ramos, J.V. SanzCasado, R. Martinez-Corria, F.H. Perera, F. Mulero, P. Miranda, J.L. Lopez-Lacomba. Biological properties
of solid free form designed ceramic scaffolds with BMP-2: in vitro and in vivo evaluation. PLoS
One, 7 (3) (2012). e34117
[37] J.P. Carrel, A. Wiskott, M. Moussa, P. Rieder, S. Scherrer, S. Durual. A 3D printed TCP/HA structure as a new
osteoconductive scaffold for vertical bone augmentation. Clin. Oral Implants Res., 27 (1) (2016), pp. 5562
[38] J.P. Carrel, A. Wiskott, S. Scherrer, S. Durual. Large bone vertical augmentation using a three-dimensional
printed TCP/HA bone graft: a pilot study in Dog Mandible. Clin. Implant Dent. Relat. Res., 18 (6) (2016),
pp. 1183-1192
[39]G.M. Cooper, E.D. Miller, G.E. Decesare, A. Usas, E.L. Lensie, M.R. Bykowski, J. Huard, L.E. Weiss, J.E. Losee, P
.G. Campbell. Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control
calvarial bone formation. Tissue Eng. Part A, 16 (5) (2010), pp. 1749-1759
[40] M. Dadsetan, T. Guda, M.B. Runge, D. Mijares, R.Z. LeGeros, J.P. LeGeros, D.T. Silliman, L. Lu, J.C. Wenke.
P.R. Brown Baer, M.J. Yaszemski, Effect of calcium phosphate coating and rhBMP-2 on bone
regeneration in rabbit calvaria using poly(propylene fumarate) scaffolds. Acta Biomater., 18 (2015),
pp. 9-20
[41] Z. Ge, X. Tian, B.C. Heng, V. Fan, J.F. Yeo, T. Cao. Histological evaluation of osteogenesis of 3D-printed polylactic-co-glycolic acid (PLGA) scaffolds in a rabbit model. Biomed. Mater., 4 (2) (2009). 021001
[42]K. Haberstroh, K. Ritter, J. Kuschnierz, K.H. Bormann, C. Kaps, C. Carvalho, R. Mulhaupt, M. Sittinger, N.C. Gel
lrich. Bone repair by cell-seeded 3D-bioplotted composite scaffolds made of collagen treated

tricalciumphosphate or tricalciumphosphate-chitosan-collagen hydrogel or PLGA in ovine critical-sized
calvarial defects. J. Biomed. Mater. Res. B Appl. Biomater., 93 (2) (2010), pp. 520-530
[43] M.M. Hatamleh, G. Bhamrah, F. Ryba, G. Mack, C. Huppa. Simultaneous computer-aided
Design/Computer-Aided manufacture bimaxillary orthognathic surgery and mandibular
reconstruction using selective-laser sintered titanium implant. J. Craniofac. Surg., 27 (7) (2016),
pp. 1810-1814
[44] S. Ishack, A. Mediero, T. Wilder, J.L. Ricci, B.N. Cronstein. Bone regeneration in critical bone defects using
three-dimensionally printed beta-tricalcium phosphate/hydroxyapatite scaffolds is enhanced by
coating scaffolds with either dipyridamole or BMP-2. J. Biomed. Mater. Res. B Appl.
Biomater., 105 (2) (2017), pp. 366-375
[45] S. Herberg, G. Kondrikova, S. PeriyasamyThandavan, R.N. Howie, M.E. Elsalanty, L. Weiss, P. Campbell, W.D. Hill, J.J. Cray. Inkjet-based
biopatterning of SDF-1beta augments BMP-2-induced repair of critical size calvarial bone defects in
mice. Bone, 67 (2014), pp. 95-103
[46]J. Jensen, J.H. Rolfing, D.Q. Le, A.A. Kristiansen, J.V. Nygaard, L.B. Hokland, M. Bendtsen, M. Kassem, H. Lysd
ahl, C.E. Bunger. Surface-modified functionalized polycaprolactone scaffolds for bone repair: in vitro
and in vivo experiments. J. Biomed. Mater. Res. A., 102 (9) (2014), pp. 2993-3003
[47]J. Jensen, C. Tvedesoe, J.H. Rolfing, C.B. Foldager, H. Lysdahl, D.C. Kraft, M. Chen, J. Baas, D.Q. Le, C.E. Bunge
r. Dental pulp-derived stromal cells exhibit a higher osteogenic potency than bone marrow-derived
stromal cells in vitro and in a porcine critical-size bone defect model. SICOT., 2 (2016), p. 16
[48] V. Keriquel, F. Guillemot, I. Arnault, B. Guillotin, S. Miraux, J. Amedee, J.C. Fricain, S. Catros. In vivo
bioprinting for computer- and robotic-assisted medical intervention: preliminary study in mice.
Biofabrication, 2 (1) (2010). 014101
[49] J.A. Kim, J. Lim, R. Naren, H.S. Yun, E.K. Park. Effect of the biodegradation rate controlled by pore
structures in magnesium phosphate ceramic scaffolds on bone tissue regeneration in vivo. Acta
Biomater., 44 (2016), pp. 155-167
[50]V.S. Komlev, V.K. Popov, A.V. Mironov, A.Y. Fedotov, A.Y. Teterina, I.V. Smirnov, I.Y. Bozo, V.A. Rybko, R.V. D
eev. 3D printing of octacalcium phosphate bone substitutes. Front. Bioeng. Biotechnol., 3 (2015), p. 81
[51] S. Konopnicki, B. Sharaf, C. Resnick, A. Patenaude, T. Pogal-Sussman, K.G. Hwang, H. Abukawa, M.J. Troulis.
Tissue-engineered bone with 3-dimensionally printed beta-tricalcium phosphate and
polycaprolactone scaffolds and early implantation: an in vivo pilot study in a porcine mandible model.
J. Oral Maxillofac. Surg., 73 (5) (2015). 1016 e1-1016 e11
[52] J.W. Lee, K.J. Kim, K.S. Kang, S. Chen, J.W. Rhie, D.W. Cho. Development of a bone reconstruction
technique using a solid free-form fabrication (SFF)-based drug releasing scaffold and adipose-derived
stem cells. J. Biomed. Mater. Res. A., 101 (7) (2013), pp. 1865-1875
[53] F. Pati, T.H. Song, G. Rijal, J. Jang, S.W. Kim, D.W. Cho. Ornamenting 3D printed scaffolds with cell-laid
extracellular matrix for bone tissue regeneration. Biomaterials, 37 (2015), pp. 230-241
[54] J.H. Shim, M.C. Yoon, C.M. Jeong, J. Jang, S.I. Jeong, D.W. Cho, J.B. Huh. Efficacy of rhBMP-2 loaded
PCL/PLGA/beta-TCP guided bone regeneration membrane fabricated by 3D printing technology for
reconstruction of calvaria defects in rabbit. Biomed. Mater., 9 (6) (2014). 065006
[55] J.L. Simon, S. Michna, J.A. Lewis, E.D. Rekow, V.P. Thompson, J.E. Smay, A. Yampolsky, J.R. Parsons, J.L. Ricci.
In vivo bone response to 3D periodic hydroxyapatite scaffolds assembled by direct ink writing. J.
Biomed. Mater. Res. A., 83 (3) (2007), pp. 747-758
[56] J.L. Simon, E.D. Rekow, V.P. Thompson, H. Beam, J.L. Ricci, J.R. Parsons. MicroCT analysis of hydroxyapatite
bone repair scaffolds created via three-dimensional printing for evaluating the effects of scaffold
architecture on bone ingrowth. J. Biomed. Mater. Res. A., 85 (2) (2008), pp. 371-377
[57] R. Smeets, M. Barbeck, H. Hanken, H. Fischer, M. Lindner, M. Heiland, M. Woltje, S. Ghanaati, A. Kolk.
Selective laser-melted fully biodegradable scaffold composed of poly(d,l-lactide) and beta-tricalcium
phosphate with potential as a biodegradable implant for complex maxillofacial reconstruction: in vitro
and in vivo results. J Biomed Mater Res B Appl Biomater, 105 (5) (2017), pp. 1216-1231

[58] D.M. Smith, J.J. Cray Jr, L.E. Weiss, E.K. Dai
Fei, S. Shakir, S.A. Rottgers, J.E. Losee, P.G. Campbell, G.M. Cooper. Precise control of osteogenesis for
craniofacial defect repair: the role of direct osteoprogenitor contact in BMP-2-based bioprinting. Ann.
Plast. Surg., 69 (4) (2012), pp. 485-488
[59] F. Tamimi, J. Torres, U. Gbureck, E. Lopez-Cabarcos, D.C. Bassett, M.H. Alkhraisat, J.E. Barralet. Craniofacial
vertical bone augmentation: a comparison between 3D printed monolithic monetite blocks and
autologous onlay grafts in the rabbit. Biomaterials, 30 (31) (2009), pp. 6318-6326
[60] J. Torres, F. Tamimi, M.H. Alkhraisat, J.C. Prados-Frutos, E. Rastikerdar, U. Gbureck, J.E. Barralet, E. LopezCabarcos. Vertical bone augmentation with 3D-synthetic monetite blocks in the rabbit calvaria. J. Clin.
Periodontol., 38 (12) (2011), pp. 1147-1153
[61] S. Zhao, J. Zhang, M. Zhu, Y. Zhang, Z. Liu, C. Tao, Y. Zhu, C. Zhang. Three-dimensional printed strontiumcontaining mesoporous bioactive glass scaffolds for repairing rat critical-sized calvarial defects. Acta
Biomater., 12 (2015), pp. 270-280
[62] F. Tamimi, J. Torres, K. Al-Abedalla, E. LopezCabarcos, M.H. Alkhraisat, D.C. Bassett, U. Gbureck, J.E. Barralet. Osseointegration of dental implants in
3D-printed synthetic onlay grafts customized according to bone metabolic activity in recipient site.
Biomaterials, 35 (21) (2014), pp. 5436-5445
[63] L. Ciocca, I.G. Lesci, O. Mezini, A. Parrilli, S. Ragazzini, R. Rinnovati, N. Romagnoli, N. Roveri, R. Scotti.
Customized hybrid biomimetic hydroxyapatite scaffold for bone tissue regeneration. J Biomed Mater
Res B Appl Biomater, 105 (4) (2017), pp. 723-734
[64] K.S. Hwang, J.W. Choi, J.H. Kim, H.Y. Chung, S. Jin, J.H. Shim, W.S. Yun, C.M. Jeong, J.B. Huh. Comparative
efficacies of collagen-based 3D printed PCL/PLGA/beta-TCP composite block bone grafts and biphasic
calcium phosphate bone substitute for bone regeneration. Materials Basel (Basel), 10 (4) (2017)
[65] D.Y. Kwon, J.H. Park, S.H. Jang, J.Y. Park, J.W. Jang, B.H. Min, W.D. Kim, H.B. Lee, J. Lee, M.S. Kim. Bone
regeneration by means of a three-dimensional printed scaffold in a rat cranial defect. J. Tissue Eng.
Regen. Med. (2017)
[66] J. Li, M. Chen, X. Wei, Y. Hao, J. Wang. Evaluation of 3D-Printed polycaprolactone scaffolds coated with
freeze-dried platelet-rich plasma for bone regeneration. Materials Basel (Basel), 10 (7) (2017)
[67] J. Li, Q. Xu, B. Teng, C. Yu, L. Song, Y.X. Lai, J. Zhang, W. Zheng, P.G. Ren. Investigation of angiogenesis in
bioactive 3-dimensional poly(d,l-lactide-co-glycolide)/nano-hydroxyapatite scaffolds by in vivo
multiphoton microscopy in murine calvarial critical bone defect. Acta Biomater., 42 (2016), pp. 389399
[68]M.G. Roskies, D. Fang, M.N. Abdallah, A.M. Charbonneau, N. Cohen, J.O. Jordan, M.P. Hier, A. Mlynarek, F. T
amimi, S.D. Tran. Three-dimensionally printed polyetherketoneketone scaffolds with mesenchymal
stem cells for the reconstruction of critical-sized mandibular defects. Laryngoscope, 127 (11) (2017),
pp. E392-E398
[69] H. Shao, X. Ke, A. Liu, M. Sun, Y. He, X. Yang, J. Fu, Y. Liu, L. Zhang, G. Yang, S. Xu, Z. Gou. Bone regeneration
in 3D printing bioactive ceramic scaffolds with improved tissue/material interface pore architecture in
thin-wall bone defect. Biofabrication, 9 (2) (2017). 025003
[70] H. Shao, M. Sun, F. Zhang, A. Liu, Y. He, J. Fu, X. Yang, H. Wang, Z. Gou. Custom repair of mandibular bone
defects with 3D printed bioceramic scaffolds. J. Dent. Res. (2017). 22034517734846
[71]J.H. Shim, J.Y. Won, J.H. Park, J.H. Bae, G. Ahn, C.H. Kim, D.H. Lim, D.W. Cho, W.S. Yun, E.B. Bae, C.M. Jeong, J
.B. Huh. Effects of 3D-Printed Polycaprolactone/beta-Tricalcium phosphate membranes on guided
bone regeneration. Int. J. Mol. Sci., 18 (5) (2017)
[72] J.W. Goetz, M.H. Levine, S.R. Iyer, E.A. Clark, J. Ricci. Repair of complex craniofacial bone defects using 3DPrinted tricalcium phosphate scaffolds. J. Oral Maxillofac. Surg., 71 (9) (2013), pp. e89-e90
[73] S. Gomez, M.D. Vlad, J. Lopez, E. Fernandez. Design and properties of 3D scaffolds for bone tissue
engineering. Acta Biomater., 42 (2016), pp. 341-350
[74] L.L. Hench. Bioceramics and the origin of life. J. Biomed. Mater. Res., 23 (7) (1989), pp. 685-703

[75] H.S. Ryu, H.J. Youn, K.S. Hong, B.S. Chang, C.K. Lee, S.S. Chung. An improvement in sintering property of
beta-tricalcium phosphate by addition of calcium pyrophosphate. Biomaterials, 23 (3) (2002), pp. 909914
[76] H. Oonishi. Orthopaedic applications of hydroxyapatite. Biomaterials, 12 (2) (1991), pp. 171-178
[77] B. Leukers, H. Gulkan, S.H. Irsen, S. Milz, C. Tille, M. Schieker, H. Seitz. Hydroxyapatite scaffolds for bone
tissue engineering made by 3D printing. J. Mater. Sci. Mater. Med., 16 (12) (2005), pp. 1121-1124
[78] D.L. Wheeler, K.E. Stokes, H.M. Park, J.O. Hollinger. Evaluation of particulate Bioglass in a rabbit radius
ostectomy model. J. Biomed. Mater. Res., 35 (2) (1997), pp. 249-254
[79] Z. Li, H.R. Ramay, K.D. Hauch, D. Xiao, M. Zhang. Chitosan-alginate hybrid scaffolds for bone tissue
engineering. Biomaterials, 26 (18) (2005), pp. 3919-3928
[80] W.J. Marijnissen, G.J. van Osch, J. Aigner, S.W. van der Veen, A.P. Hollander, H.L. VerwoerdVerhoef, J.A. Verhaar. Alginate as a chondrocyte-delivery substance in combination with a non-woven
scaffold for cartilage tissue engineering. Biomaterials, 23 (6) (2002), pp. 1511-1517
[81] H. Park, K.Y. Lee. Cartilage regeneration using biodegradable oxidized alginate/hyaluronate hydrogels. J.
Biomed. Mater. Res. A, 102 (12) (2014), pp. 4519-4525
[82] G.A. Fielding, A. Bandyopadhyay, S. Bose. Effects of silica and zinc oxide doping on mechanical and
biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds. Dent.
Mater., 28 (2) (2012), pp. 113-122
[83] M.D. Grynpas, R.M. Pilliar, R.A. Kandel, R. Renlund, M. Filiaggi, M. Dumitriu. Porous calcium polyphosphate
scaffolds for bone substitute applications in vivo studies. Biomaterials, 23 (9) (2002), pp. 2063-2070
[84] K. Madhumathi, P.T. Sudheesh Kumar, K.C. Kavya, T. Furuike, H. Tamura, S.V. Nair, R. Jayakumar. Novel
chitin/nanosilica composite scaffolds for bone tissue engineering applications. Int. J. Biol.
Macromol., 45 (3) (2009), pp. 289-292
[85] W.E. Muller, H.C. Schroder, Z. Shen, Q. Feng, X. Wang. Inorganic polymers: morphogenic inorganic
biopolymers for rapid prototyping chain. Prog. Mol. Subcell. Biol., 54 (2013), pp. 235-259
[86] J.P. Li, J.R. de Wijn, C.A. Van Blitterswijk, K. de Groot. Porous Ti6Al4V scaffold directly fabricating by rapid
prototyping: preparation and in vitro experiment. Biomaterials, 27 (8) (2006), pp. 1223-1235
[87] G.E. Ryan, A.S. Pandit, D.P. Apatsidis. Porous titanium scaffolds fabricated using a rapid prototyping and
powder metallurgy technique. Biomaterials, 29 (27) (2008), pp. 3625-3635
[88] V. Olivier, N. Faucheux, P. Hardouin. Biomaterial challenges and approaches to stem cell use in bone
reconstructive surgery. Drug Discov. Today, 9 (18) (2004), pp. 803-811
[89] J.A. Inzana, D. Olvera, S.M. Fuller, J.P. Kelly, O.A. Graeve, E.M. Schwarz, S.L. Kates, H.A. Awad. 3D printing of
composite calcium phosphate and collagen scaffolds for bone regeneration.
Biomaterials, 35 (13) (2014), pp. 4026-4034
[90] H. Wang, Y. Li, Y. Zuo, J. Li, S. Ma, L. Cheng. Biocompatibility and osteogenesis of biomimetic nanohydroxyapatite/polyamide composite scaffolds for bone tissue engineering.
Biomaterials, 28 (22) (2007), pp. 3338-3348
[91] F.A. Probst, D.W. Hutmacher, D.F. Muller, H.G. Machens, J.T. Schantz. [Calvarial reconstruction by
customized bioactive implant]. Handchir. Mikrochir. Plast. Chir., 42 (6) (2010), pp. 369-373
[92] C.K. Chua, K.F. Leong, K.H. Tan, F.E. Wiria, C.M. Cheah. Development of tissue scaffolds using selective
laser sintering of polyvinyl alcohol/hydroxyapatite biocomposite for craniofacial and joint defects. J.
Mater. Sci. Mater. Med., 15 (10) (2004), pp. 1113-1121
[93] P. Bajaj, R.M. Schweller, A. Khademhosseini, J.L. West, R. Bashir. 3D biofabrication strategies for tissue
engineering and regenerative medicine. Annu. Rev. Biomed. Eng., 16 (2014), pp. 247-276
[94]L. Koch, S. Kuhn, H. Sorg, M. Gruene, S. Schlie, R. Gaebel, B. Polchow, K. Reimers, S. Stoelting, N. Ma, P.M. Vo
gt, G. Steinhoff, B. Chichkov. Laser printing of skin cells and human stem cells. Tissue Eng. Part C
Methods, 16 (5) (2010), pp. 847-854
[95] R. Chang, J. Nam, W. Sun. Effects of dispensing pressure and nozzle diameter on cell survival from solid
freeform fabrication-based direct cell writing. Tissue Eng. Part A, 14 (1) (2008), pp. 41-48
[96] D.F. Williams. On the mechanisms of biocompatibility. Biomaterials, 29 (20) (2008), pp. 2941-2953

[97] E. De Santis, N.P. Lang, G. Favero, M. Beolchini, F. Morelli, D. Botticelli. Healing at mandibular block-grafted
sites. An experimental study in dogs. Clin. Oral Implants Res., 26 (5) (2015), pp. 516-522
[98] V. Karageorgiou, D. Kaplan. Porosity of 3D biomaterial scaffolds and osteogenesis.
Biomaterials, 26 (27) (2005), pp. 5474-5491
[99] T. Albrektsson, T. Jansson, U. Lekholm. Osseointegrated dental implants. Dent. Clin. North
Am., 30 (1) (1986), pp. 151-174
[100] M. Hallman, L. Sennerby, S. Lundgren. A clinical and histologic evaluation of implant integration in the
posterior maxilla after sinus floor augmentation with autogenous bone, bovine hydroxyapatite, or a
20:80 mixture. Int. J. Oral Maxillofac. Implants, 17 (5) (2002), pp. 635-643
[101] E. Farre-Guasch, J. Wolff, M.N. Helder, E.A. Schulten, T. Forouzanfar, J. Klein-Nulend. Application of
additive manufacturing in oral and maxillofacial surgery. J. Oral Maxillofac. Surg., 73 (12) (2015),
pp. 2408-2418
[102]A.L. Jardini, M.A. Larosa, M.F. Macedo, L.F. Bernardes, C.S. Lambert, C.A.C. Zavaglia, R.M. Filho, D.R. Calder
oni, E. Ghizoni, P. Kharmandayan. Improvement in cranioplasty: advanced prosthesis
biomanufacturing. Procedia Cirp, 49 (2016), pp. 203-208
[103] A.L. Jardini, M.A. Larosa, R. Maciel
Filho, C.A. Zavaglia, L.F. Bernardes, C.S. Lambert, D.R. Calderoni, P. Kharmandayan. Cranial
reconstruction: 3D biomodel and custom-built implant created using additive manufacturing. J.
Craniomaxillofac. Surg., 42 (8) (2014), pp. 1877-1884

